Boehringer Ingelheim runs Broadline lunch and learn competition

Boehringer Ingelheim, manufacturer of Broadline spot-on solution for cats, is running a monthly competition for veterinary professionals to win a £200 Red Letter Day voucher*.

The monthly prize draw runs until the end of December and is open to all practice staff who have participated in the Broadline lunch and learn presentation carried out by a Boehringer territory manager.

Brittany Biddle, a trainee veterinary nurse at Chantry Vets in Castleford, Yorkshire, won the Red Letter voucher in the April prize draw, with Faye Johnson from Blythman & Partners in Gateshead and Nicola Phillips from Fenton Vets in Haverfordwest winning the vouchers in the May and June prize draws respectively.

“Broadline is the only product to treat for fleas, ticks, roundworms and tapeworms in cats in a single treatment, and the Broadline lunch and learn presentation provided Chantry’s practice staff with a useful overview of the product’s benefits,” commented Brittany Biddle. “I was delighted to have won the £200 Red Letter Day voucher and would recommend that as many veterinary professionals as possible participate in both the lunch and learn presentation and the scratch card quiz prize draw.”

For further information about Broadline or the Broadline lunch and learn presentation please contact your Boehringer Ingelheim territory manager.

*Terms and conditions available upon request from Boehringer Ingelheim via post/website.

About the Animal Health Business Unit
As the second largest animal health business in the world, Boehringer Ingelheim is committed to improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries. For more information about Boehringer Ingelheim Animal Health, visit https://www.boehringer-ingelheim.com/animal-health/overview.

Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the industry’s top 20 pharmaceutical companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.
Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects, such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees’ different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.